PI3Kα-IN-243

CAS No. 1235449-52-1

PI3Kα-IN-243( PI3Kα inhibitor 1 | MDK 9521 | PI3Kα-IN-243 )

Catalog No. M10945 CAS No. 1235449-52-1

A potent PI3Kα inhibitor with IC50 of <0.1 uM; also inhibits HDAC (IC50=0.1-1 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 158 Get Quote
5MG 237 Get Quote
10MG 357 Get Quote
25MG 597 Get Quote
50MG 851 Get Quote
100MG 1152 Get Quote
500MG 2313 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PI3Kα-IN-243
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent PI3Kα inhibitor with IC50 of <0.1 uM; also inhibits HDAC (IC50=0.1-1 uM).
  • Description
    A potent PI3Kα inhibitor with IC50 of <0.1 uM; also inhibits HDAC (IC50=0.1-1 uM); compound 243 in patent US/20120088764A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PI3Kα inhibitor 1 | MDK 9521 | PI3Kα-IN-243
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1235449-52-1
  • Formula Weight
    507.5681
  • Molecular Formula
    C23H25N9O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 37 mg/mL
  • SMILES
    O=C(C1=CN=C(N(C)CC2=CC3=NC(C4=CC=C(NC)N=C4)=NC(N5CCOCC5)=C3S2)N=C1)NO
  • Chemical Name
    5-Pyrimidinecarboxamide, N-hydroxy-2-[methyl[[2-[6-(methylamino)-3-pyridinyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]amino]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Patent US/20120088764A1
molnova catalog
related products
  • mTOR inhibitor 9f

    mTOR inhibitor 9f is a selective mTOR inhibitor with IC50 of 1.25nM and 82nM for mTOR and PI3Kα, respectively.

  • 5S rRNA modificator

    5S rRNA modificator, used in 5S rRNA RNA modification, is a suitable electrophile for 2’-hydroxyl acylation on structured RNA molecules.

  • MTX-211

    A first-in-class, highly selective, dual inhibitor of PI3K and EGFR kinases.